Novartis AG annual gross profit for fiscal 2025 was $43.0 billion, an increase of 10.5% from $38.9 billion in fiscal 2024. All figures are reported results from public filings — no estimates or projections.
| Gross Profit (annual) | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Gross Profit | $43.0B | $38.9B | $34.2B | $31.9B | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Gross Profit (quarterly) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|---|
| Gross Profit | $11.2B | $10.1B | $10.2B | $10.8B | $11.5B | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
More NOVN metrics: Revenue · Operating Income · Net Income · EPS · Free Cash Flow
All NOVN financial statements → Interactive NOVN charts →
About TickerBase · Data methodology & sources · Privacy · Terms